Wealth Enhancement Advisory Services’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Wealth Enhancement Advisory Services's ANGO Position: Q2 2026 in Review
Wealth Enhancement Advisory Services opened a new position in AngioDynamics (ANGO) in Q2 2026: 13,730 shares worth $176K. The stake represents ﹤0.01% of the portfolio and ranks #3634 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in ANGO as recently as Q3 2024.
Wealth Enhancement Advisory Services first reported a position in ANGO in Q3 2024 and has held it in 2 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Wealth Enhancement Advisory Services held 13,730 shares of AngioDynamics worth $176K as of Q2 2026.
- AngioDynamics was a new Wealth Enhancement Advisory Services position in Q2 2026.
- AngioDynamics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3634 holding.
- Wealth Enhancement Advisory Services first reported a position in AngioDynamics in Q3 2024 and has held it in 2 quarters since.
- 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.